CD44 Isoform Status Predicts Response to Treatment with Anti-CD44 Antibody in Cancer Patients

F. Birzele; E. Voss; A. Nopora; K. Honold; F. Heil; S. Lohmann; H. Verheul; C. Le Tourneau; J.P. Delord; C Van Herpen; D. Mahalingam; A.L. Coveler; V. Meresse; S. Weigand; V. Runza; M. Cannarile

doi:10.1158/1078-0432.CCR-14-2141

CD44 Isoform Status Predicts Response to Treatment with Anti-CD44 Antibody in Cancer Patients

F. Birzele, E. Voss, A. Nopora, K. Honold, F. Heil, S. Lohmann, H. Verheul, C. Le Tourneau, J.P. Delord, C Van Herpen, D. Mahalingam, A.L. Coveler, V. Meresse, S. Weigand, V. Runza, M. Cannarile

Medical oncology

Research output: Contribution to journal › Article › Academic › peer-review

Original language	Undefined/Unknown
Pages (from-to)	2753-2762
Journal	Clinical Cancer Research
Volume	21
Issue number	12
DOIs	https://doi.org/10.1158/1078-0432.CCR-14-2141
Publication status	Published - 2015

Access to Document

10.1158/1078-0432.CCR-14-2141

Cite this

Birzele, F., Voss, E., Nopora, A., Honold, K., Heil, F., Lohmann, S., Verheul, H., Le Tourneau, C., Delord, J. P., Van Herpen, C., Mahalingam, D., Coveler, A. L., Meresse, V., Weigand, S., Runza, V., & Cannarile, M. (2015). CD44 Isoform Status Predicts Response to Treatment with Anti-CD44 Antibody in Cancer Patients. Clinical Cancer Research, 21(12), 2753-2762. https://doi.org/10.1158/1078-0432.CCR-14-2141

@article{4ea41c889a3a4e809555bc82700b7005,

title = "CD44 Isoform Status Predicts Response to Treatment with Anti-CD44 Antibody in Cancer Patients",

author = "F. Birzele and E. Voss and A. Nopora and K. Honold and F. Heil and S. Lohmann and H. Verheul and {Le Tourneau}, C. and J.P. Delord and {Van Herpen}, C and D. Mahalingam and A.L. Coveler and V. Meresse and S. Weigand and V. Runza and M. Cannarile",

year = "2015",

doi = "10.1158/1078-0432.CCR-14-2141",

language = "Undefined/Unknown",

volume = "21",

pages = "2753--2762",

journal = "Clinical Cancer Research",

issn = "1078-0432",

publisher = "American Association for Cancer Research Inc.",

number = "12",

}

Birzele, F, Voss, E, Nopora, A, Honold, K, Heil, F, Lohmann, S, Verheul, H, Le Tourneau, C, Delord, JP, Van Herpen, C, Mahalingam, D, Coveler, AL, Meresse, V, Weigand, S, Runza, V & Cannarile, M 2015, 'CD44 Isoform Status Predicts Response to Treatment with Anti-CD44 Antibody in Cancer Patients', Clinical Cancer Research, vol. 21, no. 12, pp. 2753-2762. https://doi.org/10.1158/1078-0432.CCR-14-2141

TY - JOUR

T1 - CD44 Isoform Status Predicts Response to Treatment with Anti-CD44 Antibody in Cancer Patients

AU - Birzele, F.

AU - Voss, E.

AU - Nopora, A.

AU - Honold, K.

AU - Heil, F.

AU - Lohmann, S.

AU - Verheul, H.

AU - Le Tourneau, C.

AU - Delord, J.P.

AU - Van Herpen, C

AU - Mahalingam, D.

AU - Coveler, A.L.

AU - Meresse, V.

AU - Weigand, S.

AU - Runza, V.

AU - Cannarile, M.

PY - 2015

Y1 - 2015

U2 - 10.1158/1078-0432.CCR-14-2141

DO - 10.1158/1078-0432.CCR-14-2141

M3 - Article

C2 - 25762343

SN - 1078-0432

VL - 21

SP - 2753

EP - 2762

JO - Clinical Cancer Research

JF - Clinical Cancer Research

IS - 12

ER -